Acticor Biotech réussi le pari du crowdfunding! By Joachim – Published on January 29, 2015 | LABIOTECH.fr Read in English : Biotech’s crowdfunding: is France top of the class? In France, you can feel a real enthousiasme for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand […]
Biotech’s crowdfunding: is France top of the class? By Joachim Eeckhout – Published on December 22, 2014 | LABIOTECH.eu In France, you can feel a real enthusiasm for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand their reasons and issues. The first of these, Acticor Biotech, […]
Acticor Biotech sélectionne son premier lead By Anne Lise Berthier – Published on November 03, 2014 | No.81 Classé parmi les urgences médicales absolues, l’accident vasculaire cérébral (AVC) touche chaque année 155 000 nouvelles personnes en France et reste une des principales causes de mortalité et la première cause de handicap acquis de l’adulte. Bien […]
Gilles Avenard, Acticor Biotech CEO is invited to talk about the relationships between Business Angels and startups in the field of human health. The “Innover et Investir dans la Santé” (Innovate and Invest in Health) conference is organized by Angels Santé, the leading Business Angels network in France, and the Public Bank for Investment (BPI), […]
Acticor Biotech cible les AVC by Thérèse Bouveret – published on November 1st, 2014, at 04:55pm | L’Usine Nouvelle n° 3396 Read the article in French on l’Usine Nouvelle website.
The full article from the French financial newspaper is available here : Acticor Biotech agit contre l’AVC avec un anticorps monoclonal